ClinConnect ClinConnect Logo
Search / Trial NCT06042751

Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom

Launched by HANNOVER MEDICAL SCHOOL · Sep 12, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Physical Actvity Psychotherapy Cobined Exercise And Psychotherapy Covid 19 Post Covid 19 Syndrom

ClinConnect Summary

This clinical trial is studying the best ways to help people who are experiencing fatigue after recovering from COVID-19, a condition known as Post-COVID-19 Syndrome. Researchers want to find out if therapy focused on talking (psychotherapy), exercise programs, or a combination of both can improve fatigue levels in patients. The trial will involve three different groups: one group will receive psychotherapy, another will participate in physical rehabilitation, and the third group will get both types of treatment. The goal is to see which approach works best for different patients over a period of three months, followed by an evaluation after another three months without treatment.

To be eligible for this trial, participants must be at least 18 years old, have been diagnosed with Post-COVID-19 Syndrome through a positive test, and score 22 or higher on a fatigue assessment scale. However, individuals who are currently involved in another study, have other medical conditions that could explain their fatigue, or have serious mental health issues are not eligible to participate. Throughout the trial, participants can expect to attend online therapy sessions lasting 50 minutes every two weeks, and researchers will also look into who benefits most from each type of therapy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged over 18 and
  • diagnosed post-Covid-19 syndrome: (positive PCR or antibody test) and Fatigue Assessment Scale (FAS) ≥ 22 points
  • Exclusion Criteria:
  • Current participation in another intervention study
  • Illnesses or functional disorders that potentially explain the fatigue symptoms otherwise
  • Any illness or impairment that the examining physician judges to preclude participation in a physical training intervention
  • Suicidality or severe mental illness (e.g. mania, acute phase of schizophrenia) that requires acute treatment.

About Hannover Medical School

Hannover Medical School (Medizinische Hochschule Hannover, MHH) is a leading academic medical institution in Germany, renowned for its commitment to innovative research and high-quality clinical care. Established in 1965, MHH specializes in a wide range of medical disciplines, with a strong focus on transplantation medicine, regenerative medicine, and personalized healthcare. The institution actively participates in clinical trials to advance medical knowledge and develop cutting-edge therapies, leveraging its state-of-the-art facilities and collaborative environment. With a dedicated team of researchers, clinicians, and support staff, Hannover Medical School aims to translate scientific findings into practical applications that improve patient outcomes and enhance the overall quality of healthcare.

Locations

Hannover, , Germany

Hannover, Lower Saxony, Germany

Patients applied

0 patients applied

Trial Officials

Uwe Tegtbur

Principal Investigator

Hannover Medical School, Institute for Sports Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported